AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

PureTech Health plc

Transaction in Own Shares Nov 13, 2023

4932_rns_2023-11-13_8a1f6ec3-69a8-4211-bd23-699f4544f4c2.html

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 1543T

PureTech Health PLC

13 November 2023

13 November 2023

PureTech Health plc

Transaction in Own Shares

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

Date of purchase: 10 November 2023
Number of ordinary shares purchased: 42,611
Highest price paid per share: 171.40p
Lowest price paid per share: 162.80p
Volume weighted average price paid per share: 164.81p

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 16,239,318 ordinary shares in treasury and has 273,228,841 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 273,228,841 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company has created a broad and deep pipeline through its experienced research and development team and its extensive network of scientists, clinicians and industry leaders that is being advanced both internally and through its Founded Entities. PureTech's R&D engine has resulted in the development of 27 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that has been filed for FDA approval. A number of these programs are being advanced by PureTech or its Founded Entities in various indications and stages of clinical development, including registration enabling studies. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points.

For more information, visit www.puretechhealth.com or connect with us on X, formerly known as Twitter, @puretechh.

Contact:

PureTech

Investor Relations

[email protected]

Individual Transactions

Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
10/11/2023 08:27:20 210 171.4 AQXE 00377884364TRLO0.1.1
10/11/2023 08:27:20 469 171.4 BATE 00377884365TRLO0.1.1
10/11/2023 08:27:20 97 170.2 TRQX 00377884366TRLO0.1.1
10/11/2023 08:27:20 469 169.6 CHIX 00377884369TRLO0.1.1
10/11/2023 08:27:20 469 171 XLON 00377884367TRLO0.1.1
10/11/2023 08:38:02 469 166.6 XLON 00377886852TRLO0.1.1
10/11/2023 09:06:52 31 167.4 XLON 00377892471TRLO0.1.1
10/11/2023 09:06:52 469 167.4 XLON 00377892473TRLO0.1.1
10/11/2023 09:06:52 438 167.4 XLON 00377892472TRLO0.1.1
10/11/2023 09:39:03 938 165.2 XLON 00377897673TRLO0.1.1
10/11/2023 09:39:04 469 165.2 BATE 00377897679TRLO0.1.1
10/11/2023 09:40:16 291 165.2 CHIX 00377897904TRLO0.1.1
10/11/2023 10:16:41 49 166.2 CHIX 00377905104TRLO0.1.1
10/11/2023 10:35:53 210 166.2 AQXE 00377908534TRLO0.1.1
10/11/2023 10:35:53 420 166.2 CHIX 00377908535TRLO0.1.1
10/11/2023 11:32:52 210 166 AQXE 00377916583TRLO0.1.1
10/11/2023 11:32:52 64 166 CHIX 00377916585TRLO0.1.1
10/11/2023 11:32:52 583 166 CHIX 00377916584TRLO0.1.1
10/11/2023 11:32:52 132 166 CHIX 00377916586TRLO0.1.1
10/11/2023 11:32:57 1488 166.6 XLON 00377916596TRLO0.1.1
10/11/2023 11:32:57 1321 166.6 XLON 00377916597TRLO0.1.1
10/11/2023 11:33:14 1035 165.6 XLON 00377916628TRLO0.1.1
10/11/2023 11:48:14 372 165.6 XLON 00377918999TRLO0.1.1
10/11/2023 11:48:14 27 165.6 XLON 00377919000TRLO0.1.1
10/11/2023 11:48:14 985 165.6 XLON 00377919001TRLO0.1.1
10/11/2023 11:48:14 871 165.6 XLON 00377919002TRLO0.1.1
10/11/2023 11:48:14 936 165.6 XLON 00377919003TRLO0.1.1
10/11/2023 11:48:14 469 165.2 BATE 00377919005TRLO0.1.1
10/11/2023 11:48:14 469 165.2 BATE 00377919004TRLO0.1.1
10/11/2023 11:49:48 97 166 TRQX 00377919247TRLO0.1.1
10/11/2023 11:55:46 22 164.8 TRQX 00377920126TRLO0.1.1
10/11/2023 11:55:46 75 164.8 TRQX 00377920128TRLO0.1.1
10/11/2023 11:55:46 1407 165 XLON 00377920127TRLO0.1.1
10/11/2023 12:15:29 123 165.2 XLON 00377924673TRLO0.1.1
10/11/2023 12:17:04 23 165.2 XLON 00377925190TRLO0.1.1
10/11/2023 12:20:52 559 165.2 XLON 00377926338TRLO0.1.1
10/11/2023 12:27:40 24 164.6 TRQX 00377927982TRLO0.1.1
10/11/2023 12:27:41 73 164.6 TRQX 00377927986TRLO0.1.1
10/11/2023 12:27:41 1407 164.6 XLON 00377927987TRLO0.1.1
10/11/2023 12:28:02 172 164 BATE 00377928080TRLO0.1.1
10/11/2023 12:28:02 158 164 CHIX 00377928081TRLO0.1.1
10/11/2023 12:28:02 116 164 CHIX 00377928082TRLO0.1.1
10/11/2023 12:28:02 515 164 CHIX 00377928083TRLO0.1.1
10/11/2023 12:28:02 17 164 CHIX 00377928084TRLO0.1.1
10/11/2023 12:28:02 297 164 BATE 00377928085TRLO0.1.1
10/11/2023 12:28:48 210 163.6 AQXE 00377928210TRLO0.1.1
10/11/2023 12:28:48 196 163.6 AQXE 00377928209TRLO0.1.1
10/11/2023 12:31:13 291 164 XLON 00377928568TRLO0.1.1
10/11/2023 12:31:13 231 164 XLON 00377928569TRLO0.1.1
10/11/2023 12:41:28 123 164 XLON 00377930529TRLO0.1.1
10/11/2023 12:42:22 580 164 XLON 00377930644TRLO0.1.1
10/11/2023 12:43:34 212 164 XLON 00377930839TRLO0.1.1
10/11/2023 12:58:33 938 163.6 XLON 00377933761TRLO0.1.1
10/11/2023 13:04:03 1141 163 XLON 00377934911TRLO0.1.1
10/11/2023 13:04:04 17 162.8 TRQX 00377934917TRLO0.1.1
10/11/2023 13:12:55 79 162.8 TRQX 00377936203TRLO0.1.1
10/11/2023 13:23:21 183 163 XLON 00377937832TRLO0.1.1
10/11/2023 13:23:21 286 163 XLON 00377937831TRLO0.1.1
10/11/2023 13:34:04 201 163 XLON 00377939578TRLO0.1.1
10/11/2023 14:06:41 67 164.4 CHIX 00377946381TRLO0.1.1
10/11/2023 14:34:47 208 163.8 CHIX 00377956468TRLO0.1.1
10/11/2023 14:35:40 261 163.8 CHIX 00377957225TRLO0.1.1
10/11/2023 14:35:40 64 163.8 CHIX 00377957226TRLO0.1.1
10/11/2023 14:35:40 467 163.8 CHIX 00377957227TRLO0.1.1
10/11/2023 14:35:40 210 163.8 AQXE 00377957229TRLO0.1.1
10/11/2023 14:35:40 1407 163.8 XLON 00377957228TRLO0.1.1
10/11/2023 14:36:04 220 163.6 BATE 00377957819TRLO0.1.1
10/11/2023 14:43:07 200 163.6 BATE 00377964092TRLO0.1.1
10/11/2023 15:02:29 469 165 CHIX 00377972744TRLO0.1.1
10/11/2023 15:02:29 210 164.8 AQXE 00377972746TRLO0.1.1
10/11/2023 15:02:29 469 165 CHIX 00377972745TRLO0.1.1
10/11/2023 15:02:29 1407 164.8 XLON 00377972747TRLO0.1.1
10/11/2023 15:02:29 384 164.4 BATE 00377972749TRLO0.1.1
10/11/2023 15:02:29 73 164.4 BATE 00377972748TRLO0.1.1
10/11/2023 15:02:29 12 164.4 BATE 00377972750TRLO0.1.1
10/11/2023 15:02:29 53 164.4 BATE 00377972751TRLO0.1.1
10/11/2023 15:02:29 57 164.4 BATE 00377972752TRLO0.1.1
10/11/2023 15:03:24 266 164.4 BATE 00377973195TRLO0.1.1
10/11/2023 15:03:24 97 164.2 TRQX 00377973196TRLO0.1.1
10/11/2023 15:11:42 240 164 XLON 00377977775TRLO0.1.1
10/11/2023 15:11:42 201 164 XLON 00377977776TRLO0.1.1
10/11/2023 15:17:45 19 163.8 XLON 00377980192TRLO0.1.1
10/11/2023 15:17:53 98 164 TRQX 00377980233TRLO0.1.1
10/11/2023 15:19:43 200 163.8 XLON 00377981054TRLO0.1.1
10/11/2023 15:27:10 267 163.4 CHIX 00377983978TRLO0.1.1
10/11/2023 15:27:10 542 163.4 CHIX 00377983979TRLO0.1.1
10/11/2023 15:27:10 469 163.4 XLON 00377983980TRLO0.1.1
10/11/2023 15:27:10 210 163.4 AQXE 00377983981TRLO0.1.1
10/11/2023 15:28:28 68 163 XLON 00377984546TRLO0.1.1
10/11/2023 15:31:08 97 164 TRQX 00377985528TRLO0.1.1
10/11/2023 15:32:38 29 163.6 XLON 00377985956TRLO0.1.1
10/11/2023 15:32:56 29 163.6 XLON 00377986163TRLO0.1.1
10/11/2023 15:35:00 446 164.4 BATE 00377986761TRLO0.1.1
10/11/2023 15:51:44 215 163.6 XLON 00377996251TRLO0.1.1
10/11/2023 15:51:44 350 163.6 XLON 00377996250TRLO0.1.1
10/11/2023 15:51:44 56 162.8 BATE 00377996252TRLO0.1.1
10/11/2023 15:51:44 938 162.8 XLON 00377996254TRLO0.1.1
10/11/2023 15:51:44 302 163.6 XLON 00377996253TRLO0.1.1
10/11/2023 15:51:44 97 162.8 TRQX 00377996255TRLO0.1.1
10/11/2023 15:51:44 97 162.8 TRQX 00377996256TRLO0.1.1
10/11/2023 15:53:05 72 163 AQXE 00377997315TRLO0.1.1
10/11/2023 15:58:00 69 163 AQXE 00378000050TRLO0.1.1
10/11/2023 15:58:43 455 163 BATE 00378000314TRLO0.1.1
10/11/2023 15:59:08 190 163 AQXE 00378000482TRLO0.1.1
10/11/2023 15:59:08 69 163 AQXE 00378000481TRLO0.1.1
10/11/2023 15:59:08 14 163 BATE 00378000483TRLO0.1.1
10/11/2023 16:02:15 58 162.8 XLON 00378001890TRLO0.1.1
10/11/2023 16:03:40 1349 162.8 XLON 00378002596TRLO0.1.1
10/11/2023 16:27:40 938 164 XLON 00378021235TRLO0.1.1
10/11/2023 16:29:25 242 163.8 CHIX 00378022177TRLO0.1.1
10/11/2023 16:29:48 937 164 XLON 00378022739TRLO0.1.1
10/11/2023 16:29:49 83 164 XLON 00378022749TRLO0.1.1
10/11/2023 16:29:49 2277 164 XLON 00378022750TRLO0.1.1
10/11/2023 16:29:57 54 164 XLON 00378022910TRLO0.1.1

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

POSFLFFALDLILIV

Talk to a Data Expert

Have a question? We'll get back to you promptly.